First interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017Psoriatic Arthritis
Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic Arthritis
Ustekinumab trumps TNF-blockade for enthesitis in patients with psoriatic arthritisJune 17, 2017Psoriatic Arthritis
_web.jpg)
